Kambis Mashayekhi

TL;DR: In this paper, the authors identified seven common principles that are widely accepted as best practices for chronic total occlusion percutaneous coronary intervention (PCI) in CTO-PCI.

TL;DR: There is a need for an updated document that includes data from recent clinical trials and registries, information on novel devices and techniques, and an up-to-date revision on the training requirements to approach CTO PCI.

TL;DR: CTO PCI resulted in clinical benefit over no CTO PCI, as evidenced by reduced major adverse coronary event rates at 12 months, and similar results were obtained for other indexes of regional and global left ventricular function.

TL;DR: The Chronic Total Occlusion Academic Research Consortium (CTRAC) as discussed by the authors is a broad consortium comprising academicians, practicing physicians, researchers, medical society representatives, and regulators (US Food and Drug Administration) to develop methods, end points, biomarkers, parameters, data, materials, processes, procedures, evaluations, tools and techniques for CTO interventions.

TL;DR: Chronic total occlusion percutaneous coronary intervention has shown a steady increase in procedural success rate over time, with unchanged complication rates, despite the increasing complexity of the lesions attempted.